Literature DB >> 16019565

Chronic myeloid leukemia presenting with extramedullary disease as massive ascites responding to imatinib mesylate.

Aamer Aleem1, Neelam Siddiqui.   

Abstract

Patients with chronic myeloid leukemia (CML) can develop extramedullary involvement during the course of the illness. This usually occurs during the accelerated phase or blast crisis. We describe a patient who presented with massive ascites probably due to mesenteric/peritoneal infiltration during chronic phase CML. There was an excellent response to imatinib with a complete cytogenetic response and total disappearance of ascites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16019565     DOI: 10.1080/10428190500096781

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  5 in total

1.  Chronic Myeloid Leukemia with Extramedullary Blast Crisis: Two Unusual Sites with Review of Literature.

Authors:  Kamal Kant Sahu; Pankaj Malhotra; Preithy Uthamalingam; Gaurav Prakash; Amanjit Bal; Neelam Varma; Subhash Chandar Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-10-29       Impact factor: 0.900

2.  A case of leukemic pleural infiltration in atypical chronic myeloid leukemia.

Authors:  Hyun Woo Kim; Sung Sook Lee; Min-Hee Ryu; Jae Lyun Lee; Heung Moon Chang; Tae Won Kim; Hyun-Sook Chi; Woo Kun Kim; Jung Shin Lee; Yoon-Koo Kang
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

Review 3.  Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.

Authors:  Xiaoning Gao; Jie Li; Lili Wang; Ji Lin; Hongshi Jin; Yihan Xu; Nan Wang; Yu Zhao; Daihong Liu; Li Yu; Quanshun Wang
Journal:  Am J Case Rep       Date:  2016-10-27

Review 4.  Serous fluids and hematolymphoid disorders.

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

5.  A Rare Monocytic Crisis of Chronic Myelogenous Leukemia Presenting with Unusual Extramedullary Manifestations and an Atypical (14;22)(q24;q11.2) Translocation in the Bone Marrow.

Authors:  Morihiro Inoue; Masao Hagihara; Tomoyuki Uchida; Jian Hua; Takeshi Nakajima; Shogo Tajima; Yasunori Ota
Journal:  Intern Med       Date:  2017-10-11       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.